PubMed · 5976168
The source did not provide an abstract. Follow the original record for more information.
Explore connections, maps & timelines
E Gladtke, G Beneke. 1966-12-17. [Giant-cell hepatitis].. https://pubmed.ncbi.nlm.nih.gov/5976168/
Cite the original work for its findings. Save a collection to share your selection of sources.
KEEP EXPLORING
An anonymous questionnaire was sent to the lead consultant obstetricians and the midwives in charge of the antenatal clinics of all maternity units in UK to determine their current views on the diagnosis and management of obstetric cholestasis (OC). The response rate was 60%. Management policies were broadly similar and consistent with those recommended in the current literature. However, the survey highlighted areas for improvement. Based on the findings of this survey, a consensus view of the management of OC in UK is achievable.
Cholestasis, a frequent occurrence in clinical practice, can be suspected when confronted to clinical signs (pruritus and jaundice) and/or increased blood level of alkaline phosphatases, gammaglutamyl transpeptidase and/or conjugated bilirubin. This short review will deal with the management of clinical manifestations and extrahepatic complications, whatever the cause of cholestasis. The management according to etiology will be dealt with in a separated chapter.
Explore the source record for details and available documents.